Cross-linked Sodium Hyaluronate Gel with PVA Microspheres for Medical Purposes
The product is indicated for injection into the supraperiosteal layer of adults for the improvement of mild to moderate retrogenia
Class III Medical Device
Cross-linked Sodium Hyaluronate, PVA Microspheres, Lidocaine Hydrochloride, Balanced Salt Solution
0.5 mL, 0.75 mL, 1.0 mL, 2X0.5mL, 2X0.75 mL, 2X1.0mL, 4X0.5mL, 4X0.75 mL, 4X1.0mL
This filler provides structural support through injection into the supraperiosteal layer to restore contour and achieve clinical correction.
For most patients after two treatment sessions, the corrective effect remains effective at 60 weeks post-initial injection.
Consultation and Purchase
